Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity?
- PMID: 16197364
- DOI: 10.1517/14656566.6.12.2141
Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity?
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical